NOCO Drug Testing Funding: How Much Did They Raise & Key Investors

How Much Did NOCO Drug Testing Raise?
Funding & Key Investors

NOCO Drug Testing has secured $11K in total financing, with a recent capital infusion of $11K to fuel its moderate growth. This funding round positions the company for its Series A/B growth stage, indicating a strategic move towards scaling operations and expanding its market reach in the critical field of drug and alcohol testing services.

What is NOCO Drug Testing?

NOCO Drug Testing

Business Services

Document Management

Healthcare Services

NOCO Drug Testing, LLC, based in Northern Colorado, is a specialized provider of 24/7 accredited drug and alcohol testing. With over three and a half decades of experience, the company offers comprehensive solutions for both employers and individuals, including DOT and non-DOT drug screens, policy review, and essential training. Their established reputation for accuracy and prompt results underscores their role as a leader in ensuring workplace safety and regulatory compliance through meticulous testing management.

How much funding has NOCO Drug Testing raised?

NOCO Drug Testing has raised a total of $11K across 1 funding round:

2021

Debt

$11K

Debt (2021): $11K with participation from PPP

What's next for NOCO Drug Testing?

The Series A/B growth stage funding signifies NOCO Drug Testing's commitment to expanding its service offerings and geographical footprint. This strategic investment is expected to enhance their technological capabilities, potentially broaden their client base, and further solidify their position as a trusted partner in workplace safety and compliance. The company is poised to leverage this capital for sustained development and market penetration.

See full NOCO Drug Testing company page

See More Financial Insights